What Angela didn't mention is that, being on a synthetic route to
LSD, posession is heavily regulated - as Home Office Schedule 1 - so
spiking is not a realistic option for EQA providers . . .
Best wishes
David
On 6 Oct 2011 at 16:58, Kremmyda Angela wrote:
> Thank you very much to all who replied.
>
> Apparently 3-methoxytyramine is included in the ‘Biogenic Amines’ of
> the Australian EQA scheme (http://www.rcpaqap.com.au/) and UK NEQAS
> have just agreed to include it as an additional analyte to their
> scheme.
>
Dr David Bullock
Director, UK NEQAS
Birmingham Quality
P O Box 3909
Birmingham B15 2UE
FAX 0121 414 1179 [+44 121 414 1179]
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|